A METHOD, USES, SYSTEM AND KIT FOR DETECTING A HUMAN PAPILLOMAVIRUS GENOTYPE ASSOCIATED WITH DEVELOPMENT OF CERVICAL, ORAL OR ANOGENITAL CANCER IN A SUBJECT AND FOR DETERMINING THE GENOTYPE OR GENOTYPES THEREOF

A METHOD, USES, SYSTEM AND KIT FOR DETECTING A HUMAN PAPILLOMAVIRUS GENOTYPE ASSOCIATED WITH DEVELOPMENT OF CERVICAL, ORAL OR ANOGENITAL CANCER IN A SUBJECT AND FOR DETERMINING THE GENOTYPE OR GENOTYPES THEREOF

The invention relates to a method, uses, system and kit for detecting a human papillomavirus (HPV) genotype associated with development of cervical, oral or anogenital cancer in a subject and for determining the genotype or genotypes of HPV thus detected therein. Additionally, the present invention...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PÉREZ GUERRERO, Laura, FERNÁNDEZ DELGADO, Fátima, JIMÉNEZ FERNÁNDEZ, Ángel Francisco, DE LAS HERAS DE LÓZAR, Francisco, CARRERO LÉRIDA, Juana, JIMÉNEZ GONZÁLEZ, Daniel, OLMO SEVILLA, Asunción, CASCALES BARRIO, Jesús, DURÁN LOBATO, Marco Jesús, ÁLVAREZ FERNÁNDEZ, María Stela
Format: Patent
Sprache:eng ; fre
Schlagworte:
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
ENZYMOLOGY
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
PROCESSES OF PREPARING SUCH COMPOSITIONS
SPIRITS
VINEGAR
WINE
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention relates to a method, uses, system and kit for detecting a human papillomavirus (HPV) genotype associated with development of cervical, oral or anogenital cancer in a subject and for determining the genotype or genotypes of HPV thus detected therein. Additionally, the present invention relates to uses of forward and/or reverse primers or amplicons generated by multiplex real-time PCR comprising a molecular tag for identifying marker of the genotype (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66) and/or (68) of the human papillomavirus. L'invention concerne un procédé, des utilisations, un système et un kit permettant de détecter un génotype de papillomavirus humain (HPV) associé au développement d'un cancer du col de l'utérus, buccal ou anogénital chez un sujet et de déterminer le ou les génotypes de HPV ainsi détectés chez ce dernier. En outre, la présente invention concerne l'utilisation d'amorces sens et/ou antisens ou d'amplicons générés par PCR multiplex en temps réel comprenant un marqueur moléculaire pour l'identification du marqueur du génotype (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66) et/ou (68) du papillomavirus humain.